Actively Recruiting
Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block
Led by Fayoum University · Updated on 2024-10-15
90
Participants Needed
2
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In 2012 Blanco et al. \[1\] described the ultrasound technique for Pectoral nerve (PECS) block as a new, less invasive regional analgesic technique for breast surgeries. PECS block includes PECS I and PECS II (modified PECS I) interfascial blocks. Since that time, PECS block has been used successfully with good results for a wide variety of surgeries on the chest wall such as radical mastectomies, breast-conserving surgeries, breast implant placement, automated implantable cardioverter-defibrillator (AICD)/pacemaker placement, intercostal drainage tube placement, and rib fractures. In this study, the investigators hypothesized that adding dexmedetomidine as an adjuvant to ropivacaine can result in the prolongation of the duration of anesthesia with improvement of the quality of postoperative analgesia of bilateral PECS block for patients undergoing cardiac surgery via midline sternotomy compared with using only plain ropivacaine.
CONDITIONS
Official Title
Dexmedetomidine Ropivacaine Versus Plain Ropivacaine in Bilateral Pectoralis Nerve (PECS) Block
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 20 to 65 years
- Ejection fraction greater than 35%
- Elective isolated coronary artery bypass grafting (CABG) or valve surgery
You will not qualify if you...
- Poor left ventricular function requiring intra-aortic balloon pump support
- Recent myocardial infarction within the last seven days
- Combined heart or vascular procedures along with CABG
- Emergency surgery or redo cases
- Liver or kidney failure with creatinine levels above 1.5
- Hemodynamic instability
- Infection at the site of nerve block
- Allergy to local anesthetics
- Psychiatric illness
- Prolonged postoperative ventilatory support
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Fayoum University Hospital
Al Fayyum, Egypt, 63511
Completed
2
Mohamed Hamed
Al Fayyum, Egypt, 63511
Actively Recruiting
Research Team
M
mina fam, M.D
CONTACT
M
Mostafa Elhamamsy, M.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here